Search - tctmd.com

Displaying 781 - 800 of 818

Sort: Relevancy | Date

Presentation TCT 2012

Balloon-Expandable vs. Self-Expanding vs. Covered Stents In Iliac Arteries: Insights from Clinical Trials and Clinical Practice

Presenter: Tony Das

October 23, 2012

News Conference News TCT 2012

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: STAMPEDE (Bariatric Surgery) and PCSK9 (LDL Reduction)

Presenter: Elizabeth Jackson

October 23, 2012

Presentation TCT 2012

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

Presenter: David Morrow

October 23, 2012

Presentation TCT 2012

What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice?

Presenter: Gregg Stone

October 22, 2012

Presentation TCT 2012

Phase II and III Clinical Trials: Off and Running!

Presenter: Amit Patel

October 22, 2012

Presentation TCT 2012

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Presenter: Philippe Genereux

October 22, 2012

News Conference News TCT 2012

Several Trials Highlight DES Comparisons

October 22, 2012

News Conference News TCT 2012

Review of TAVR Use Offers Significant Advances, Positive Outcomes

October 22, 2012

News Conference News TCT 2012

Meta-Analyses Show Improved Outcomes with DES vs. BMS

October 22, 2012

Presentation TCT 2012

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

Presenter: Carlos Mena

October 22, 2012

News Conference News TCT 2012

COURAGE, FAME: Revascularization More Effective Than OMT

October 22, 2012

Presentation TCT 2012

Composite Endpoints in Clinical Trials: Why Do We Need Them and How Do You Interpret Them?

Presenter: Giuseppe Biondi Zoccai

October 22, 2012

Presentation TCT 2012

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

Presenter: Klaus Bonaventura, Steffen Sonntag, Franz Xaver Kleber

January 03, 2012

News Conference News

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

November 22, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Conference News

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

November 09, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

Advertisement

Balloon-Expandable vs. Self-Expanding vs. Covered Stents In Iliac Arteries: Insights from Clinical Trials and Clinical Practice

PARADOX: Smoking Enhances Effect of Clopidogrel, Prasugrel Unaffected by Smoking Status

Late Breaking Clinical Trials: STAMPEDE (Bariatric Surgery) and PCSK9 (LDL Reduction)

Late Breaking Clinical Trials: CORONARY (On-Pump vs. Off-Pump CABG), CPORT (Nonprimary PCI Without Surgical Backup), ASCERT (CABG vs. PCI), and TRAP2-TIMI 50 (Vorapaxar for...

What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice?

Phase II and III Clinical Trials: Off and Running!

Calcified Lesions: New Insights in Stable CAD and ACS from Large-Scale Clinical Trials

Several Trials Highlight DES Comparisons

Review of TAVR Use Offers Significant Advances, Positive Outcomes

Meta-Analyses Show Improved Outcomes with DES vs. BMS

Is Myocardial Infarction a Reasonable or Relevant Endpoint to Assess Carotid Intervention and Stroke Prevention Therapies in Clinical Practice and Trials?

COURAGE, FAME: Revascularization More Effective Than OMT

Composite Endpoints in Clinical Trials: Why Do We Need Them and How Do You Interpret Them?

Incidence of acute thrombosis after percutaneous coronary intervention with paclitaxel eluting balloons in a clinical setting and in clinical trials

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

Two New SES Show Improvement Over First-Generation Stents

RIFLE STEACS: Radial Approach Safer Than Femoral in STEMI

RAPID GENE: Validation of Point-of-Care Genetic Testing

Complications After TAVR: Manageable, But Important to Consider

Safety, Efficacy Reported with FIREHAWK SES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content